Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.92K Sell
10,700
-300
-3% -$124 ﹤0.01% 12830
2025
Q4
$6.18K Buy
+11,000
New +$11.5K ﹤0.01% 12457
2025
Q3
Sell
-35,500
Closed -$64.6K 13667
2025
Q2
$64.6K Buy
35,500
+6,800
+24% +$14.8K ﹤0.01% 11638
2025
Q1
$63.4K Sell
28,700
-37,300
-57% -$137K ﹤0.01% 12044
2024
Q4
$273K Buy
66,000
+64,900
+5,900% +$196K ﹤0.01% 9844
2024
Q3
$1.87K Sell
1,100
-22,900
-95% -$38.7K ﹤0.01% 13801
2024
Q2
$39.8K Sell
24,000
-24,800
-51% -$91.2K ﹤0.01% 11997
2024
Q1
$534K Buy
48,800
+40,000
+455% +$239K ﹤0.01% 8248
2023
Q4
$32.3K Sell
8,800
-26,900
-75% -$67.9K ﹤0.01% 12210
2023
Q3
$110K Buy
35,700
+1,300
+4% +$5.95K ﹤0.01% 10774
2023
Q2
$164K Sell
34,400
-8,100
-19% -$44.7K ﹤0.01% 10199
2023
Q1
$184K Buy
42,500
+4,900
+13% +$31.2K ﹤0.01% 10320
2022
Q4
$186K Sell
37,600
-75,000
-67% -$933K ﹤0.01% 10262
2022
Q3
$1.9M Buy
+112,600
New +$2.07M ﹤0.01% 5687
2022
Q2
Sell
-8,600
Closed -$225K 13705
2022
Q1
$225K Buy
+8,600
New +$241K ﹤0.01% 11245

Other funds holding NOTV

Citadel Advisors's NOTV Position: Q4 2025 in Review

Citadel Advisors sold out of Inotiv (NOTV) in Q4 2025, closing a stake of 255,858 shares — an estimated $267K sold.

Citadel Advisors first reported a position in NOTV in Q1 2014 and held it in 25 quarters. The position peaked at $1.54M in Q1 2022. 57 funds tracked by Wall St. Rank hold NOTV as of Q4 2025.

  • Citadel Advisors reported no remaining Inotiv position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 255,858 Inotiv shares in Q4 2025, an estimated $267K.
  • Citadel Advisors first reported a position in Inotiv in Q1 2014 and held it in 25 quarters.
  • Citadel Advisors's Inotiv position peaked at $1.54M in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Inotiv as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.